SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla's stock is trending due to a technical breakout and anticipation of Q3 delivery numbers, sparking discussions about potential for a continued rally, with some community members eyeing the $400-$450 range, while others caution against the move. Community discussions also highlight Elon Musk's renewed involvement in politics and potential impacts on the company, with mixed sentiments on the stock's future.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

Dog (Bitcoin) is trending as the community rallies around its fair launch and strong community, emphasizing its position as the top memecoin on the Bitcoin network. Discussion centers on its unique aspects, such as being Bitcoin-native and community-driven, with some comparing it to other meme coins. Some users are excited about the backing of a public company.

Asset Entities, Inc. engages in providing social media marketing and content delivery services. It offers its services to Discord, TikTok, and other social media platforms. It also designs, develops and manages servers for communities on Discord. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani and Kyle Fairbanks on August 1, 2020 and is headquartered in Dallas, TX.

Asset Entities Inc - Ordinary Shares - Class B

Asset Entities Inc.

Asset Entities Inc. ($ASST) is trending due to its recent merger with Strive, a strategic pivot towards Bitcoin asset management, and chatter about a potential short squeeze. Community members are closely watching for pre-market trading availability and any news regarding Bitcoin purchases, while also discussing potential broker restrictions and the implications of a CUSIP change. The merger, combined with high short interest and borrow fees, fuels speculation about significant price movement.

Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.

Helius Medical Technologies Inc - Ordinary Shares - Class A

Helius Medical Technologies Inc

HSDT is trending as traders discuss its potential for a short squeeze and upcoming FDA submission for its stroke treatment device. Community members are highlighting the low float and positive trial data, anticipating a significant price movement. Discussions also include the company's cash runway and the potential for institutional investment.

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.

Atyr Pharma Inc

aTyr Pharma, Inc

aTyr Pharma ($ATYR) is trending as investors anticipate Phase 3 trial results for Efzofitimod in pulmonary sarcoidosis, expected mid-September, with the community actively debating the likelihood of success and potential outcomes. The stock's high short interest and options volatility are fueling discussions about a potential short squeeze, while some analysts express optimism based on trial design and recent company hires. Community members are weighing bullish and bearish perspectives, analyzing the science, and monitoring for potential data leaks, creating heightened speculation around the upcoming catalyst.

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

Avantis ($AVNT.X) is trending due to a recent listing on major exchanges like Binance and Upbit, sparking significant volume and price movement. The community is excited about the potential for price exploration, drawing comparisons to $MYX.X and anticipating further gains. Many believe the coin is currently undervalued, and are watching for it to hit $1 and beyond.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending due to news of China conducting an antitrust investigation, sparking concerns about potential impacts on the company's market access. The community is debating the significance of this probe, with some viewing it as a routine negotiation tactic and others fearing a violent pullback given stretched valuations. Broader discussions involve China's push to develop domestic AI chip alternatives and the implications for US equities.

Newegg Commerce, Inc. is an e-commerce company. It offers direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products. The firm also provides third-party logistics services globally. The company was founded on July 22, 2003 and is headquartered in City of Industry, CA.

Newegg Commerce Inc

Newegg ($NEGG) is trending amid discussions of a potential short squeeze, with community members pointing to high short interest and borrow fees. Some traders are analyzing recent insider buying activity, particularly by Vlad Galkin, while others speculate about potential catalysts or future price movements. Concerns about the company's fundamentals are also being discussed.

mF International Ltd. is a holding company, which engages in the development and provision of financial trading solutions through its subsidiary. It offers real-time mission critical forex, bullion and commodities trading platform solutions, financial value-added services, mobile applications, and financial information for brokers and institutional clients via internet or platform as software as a service. The company was founded by Tai Wai Lam and Chi Weng Tam on June 15, 2022, and is headquartered in Hong Kong.

mF International Ltd - Ordinary Shares - Class A

mF International Ltd

mF International is trending due to community speculation around its low float and potential connection to a crypto exchange, with some drawing parallels to past high-flying stocks. A recent SEC filing and the company's existing financial trading platform are also fueling discussion.  Traders are closely watching key price levels and anticipating a potential breakout.

Grab Holdings Ltd. engages in the provision of millions of people each day to access its driver- and merchant-partners to order food or groceries, send packages, hail a ride or taxi, pay for online purchases or access services such as lending, insurance, wealth management and telemedicine, all through a single “everyday everything” app. The firm operates in food deliveries and mobility and by TPV in the e-wallets segment of financial services in Southeast Asia. It operates across the deliveries, mobility and digital financial services sectors in eight countries namely: Cambodia, Indonesia, Malaysia, Myanmar, the Philippines, Singapore, Thailand and Vietnam. The company was founded by Anthony Tan Ping Yeow and Tan Hooi Ling in 2012 and is headquartered in Singapore.

Grab Holdings Limited - Ordinary Shares - Class A

Grab Holdings Limited

GRAB is trending due to positive sentiment around its potential for growth in Southeast Asia, particularly as it nears profitability, with community members on X discussing a possible merger and institutional buying. The stock is also seeing increased chatter after breaking out of a multi-year base, drawing comparisons to other high-growth narratives, and analysts are highlighting its attractive valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Retail chatter around UnitedHealth Group picked up late Sunday after a report said the insurer had sought meetings with U.S. President Donald Trump as it faces criminal and civil probes into its Medicare Advantage business and federal payment changes that have cut into results.&nbsp;The Wall Street Journal&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.wsj.com/business/unitedhealth-is-spending-big-on-trump-allies-to-fix-its-washington-problems-8ca64351">noted</a> that no meeting with Trump has been secured, but UnitedHealth has already spoken with senior Justice Department officials, including Attorney General Chief of Staff Chad Mizelle, in a rare early-stage discussion about government investigations.CEO Stephen Hemsley, who returned to the top role in May, has also reportedly met White House Chief of Staff Susie Wiles and separately dined with Medicare chief Chris Klomp, where billing policies and supplemental benefits were discussed, the report said.&nbsp;<a href="https://stocktwits.com/symbol/UNH">UnitedHealth</a> has lost about 40% of its market value since April and posted a 30% drop in June-quarter profit, its first decline in more than three years, amid new Medicare billing rules and regulatory scrutiny.The company has doubled lobbying outlays to $7.7 million in the first half of 2025, disclosure filings show,&nbsp;making it a record spending by the insurer.&nbsp;It has apparently turned to Trump-linked&nbsp;allies, including fundraiser Brian Ballard, former Justice Department official Jesse Panuccio, and Trump’s personal lawyer Robert Giuffra, who replaced a prior team of attorneys at WilmerHale. Ballard’s firm has become UnitedHealth’s highest-paid outside lobbyist.UnitedHealth, which generated more than $100 billion from Medicare Advantage last year, has said it is cooperating with federal requests and remains confident in its practices. The regulatory overhang comes as Medicare chief Mehmet Oz has vowed to crack down on billing tactics across the industry, intensifying investor concern about the company’s most profitable business line.UnitedHealth won some relief in August when the Justice Department cleared its long-delayed $3.3 billion acquisition of home-health provider Amedisys after divestitures.On Stocktwits, retail sentiment was ‘bullish’ amid ‘high’ message volume.One user said they expect UnitedHealth shares to test $380 this week, pointing to Trump and his allies as a major factor, adding that the stock is “not just recovering but entering the game all over again big time.”<stembedurl>https://stocktwits.com/MomentumWins/message/628641407</stembedurl>Another user noted that CEO Stephen Hemsley is “doing what he does best” by getting the company back on track after meeting with White House Chief of Staff Susie Wiles and Medicare official Chris Klomp.&nbsp;They described the outlook as “very bullish,” citing recent investor meetings and the appointment of new CFO Wayne DeVeydt, and suggested the stock could push above $400.<stembedurl>https://stocktwits.com/DerekQuick/message/628632142</stembedurl>UnitedHealth’s stock has declined 29.5% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a smartphone displays the logo of UnitedHealth Group Incorporated. (Photo illustration by Cheng Xin/Getty Images)

UnitedHealth Pushes For Trump Meeting As DOJ Probe Deepens, Doubles Down On Lobbying — Retail Traders Remain ‘Bullish’

The company’s CEO, Stephen Hemsley, has met senior White House and Medicare officials while also hiring Trump-linked lobbyists to navigate regulatory scrutiny.

Equity

Elevance Health Shrinks to Grow Stronger: From Part D to Plan B?

ELV exits Part D and trims Medicare Advantage markets, betting on stronger-margin plans to protect profitability.

CVS Health Makes Headway in Stabilizing Aetna: What's Driving It?

CVS makes progress in stabilizing Aetna with leadership, risk management and operational changes.

Bank of America (BofA) raised its price target on Humana to $330 from $312 on Tuesday, pointing to improved sentiment in the managed care sector following UnitedHealth’s preliminary Medicare Advantage Star Ratings update.&nbsp;The bank’s research arm&nbsp;maintained a ‘Neutral’ rating on Humana shares,&nbsp;which rose on Wednesday following the worst one-day drop in over a year in the previous session after reports suggested that the cut points for the 2026 Medicare Advantage Stars Ratings, due for official release in October, will be more stringent.Analyst Kevin Fischbeck said UnitedHealth’s stronger-than-expected ratings data prompted BofA to assign a higher peer multiple to Humana. However, he cautioned that uncertainty over 2027 Medicare Advantage rates could delay the company’s earnings recovery.Meanwhile, analysts at Raymond James said the latest news about ratings "potentially pours cold water" on hopes that Humana could win back some of its lost ratings in 2026, a year earlier than management had guided. The research firm stated that the stock "was getting a little ahead of itself" following its surge from the year's nadir in July. Still, Raymond James sees the pullback as a buying opportunity, reaffirming its 'Outperform' rating and arguing that Humana's implied 2028 valuation now stands at just 6.7 times its earnings per share.&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/united-health-fuels-bullish-mood-with-4-month-high-close-as-medicare-star-ratings-reaffirmed-2025-outlook-ease-investor-fears/chwjCVnRdM9">UnitedHealth said about 78% of its members</a> are expected to be in plans rated four stars or higher for Star Year 2026, an improvement from last year and in line with historical averages.&nbsp;The insurer reaffirmed its 2025 adjusted earnings outlook of at least $16 per share, on revenue between $445.5 billion and $448 billion, including its recent&nbsp;acquisition of Amedisys.Wall Street analysts said the update was “better than feared,” even as tougher Consumer Assessment of Healthcare Providers and Systems (CAHPS) cut points raised the bar.&nbsp;Truist raised its target on UnitedHealth to $365 from $310 with a ‘Buy’ rating, while JPMorgan and Barclays reiterated ‘Overweight’ calls, saying the disclosure should ease investor concerns. Leerink, which kept an ‘Outperform’ rating, said the performance was notable given that 58% of 2026 measures were tougher.The preliminary disclosure, covering Star Year 2026 and Payment Year 2027, is a key driver of future Medicare Advantage reimbursements.&nbsp;On Stocktwits, retail sentiment was 'extremely bullish' for Humana amid 'extremely high' message volume, while it was 'bullish' for UnitedHealth with 'high' volume.So far this year,&nbsp;<a href="https://stocktwits.com/symbol/HUM">Humana’s stock</a> has risen 8.6%, while&nbsp;<a href="https://stocktwits.com/symbol/UNH">UnitedHealth’s stock</a>&nbsp;has declined 30.7% over the same period.For updates and corrections, email newsroom[at]stocktwits[dot]com.

The MyHumana app page is displayed on a smartphone in the Apple App Store in front of the Humana Inc logo on October 30, 2024 in Chongqing, China. (Photo by Cheng Xin/Getty Images)

Humana Stock In Focus: BofA Raises Price Target After UnitedHealth Stars Data, Raymond James Sees Buying Opportunity

The brokerage lifted its price target on Humana to $330 but kept a ‘Neutral’ rating, citing lingering uncertainty over 2027 Medicare Advantage rates.

UnitedHealth Finds Its Stars, Soars 8.6% as Humana Trips on Cut Points

UNH surges 8.6% as it projects stable Medicare Advantage star ratings, easing investor worries over performance.

The Zacks Analyst Blog Highlights Nebius, Microsoft, UnitedHealth, Apple and Oracle

Nebius, Microsoft, UnitedHealth, Apple, and Oracle drive market buzz as AI deals, Medicare gains, and cloud growth shake up stocks.

Stock Market News for Sep 10, 2025

Wall Street closed higher on Tuesday, driven by utilities and healthcare stocks.

UnitedHealth shares closed up nearly 9%&nbsp;at a nearly four-month high on Tuesday after Wall Street analysts said&nbsp;the health insurer’s preliminary Medicare Advantage star ratings came in better than feared, even as industry benchmarks for Stars grew tougher.The insurer said about 78% of its members are expected to be in plans rated four stars or higher for Star Year 2026, up from last year and consistent with historical averages.&nbsp;UnitedHealth also reaffirmed its 2025 adjusted earnings outlook,&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/unitedhealth-announces-disappointing-full-year-guidance-q2-earnings/cho9MXLR5Uo">first issued in July</a>, when it forecast revenue of $445.5 billion to $448.0 billion and adjusted earnings of at least $16 per share, down from $27.66 in 2024. The guidance includes the recently closed acquisition of Amedisys.Leerink said the disclosure was “better than feared,” highlighting UnitedHealth’s performance despite tougher Consumer Assessment of Healthcare Providers and Systems (CAHPS) cut points and new weighting factors. The&nbsp;research firm, which&nbsp;maintained an ‘Outperform’ rating, also noted that UnitedHealth appeared to have broken from the traditional ‘embargo period,’ where plans typically hold ratings details until official publication by the Centers for Medicare &amp; Medicaid Services (CMS).Truist raised its price target on the stock to $365 from $310 while maintaining a ‘Buy’ rating, calling the update a “solid” first look at 2026.&nbsp;JPMorgan analyst Lisa Gill reiterated an ‘Overweight’ rating, writing that the data was “likely better than some investors feared,” while Barclays kept an ‘Overweight’ stance with a $352 target, saying the news “should help alleviate investor concerns” and reinforced its thesis of multi-year margin improvement.Leerink added that CMS released cut points for Star Year 2026 and Payment Year 2027 through the HPMS system on Monday night, which is how UnitedHealth was able to disclose its percentages ahead of a conference presentation. “It is possible that if UNH did better, someone could have done worse,” Mayo wrote, noting that cut points overall looked “challenged.”Hyperlift’s Phillip Collins, in a&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.linkedin.com/posts/activity-7371216302113431552-uY54/?utm_source&amp;#61;share&amp;utm_medium&amp;#61;member_desktop&amp;rcm&amp;#61;ACoAABXrWbQBsbu0mnmdP2RjAc2t4fwWighMA3I">LinkedIn post</a>, said the 2026 cut points represented “another hard year,” noting that 58% of the measures got harder, 17% easier and 25% stayed the same.&nbsp;Pharmacy measures were especially difficult, with 15 cut points getting tougher and only one easing. Collins said technical specifications also showed declines in colorectal screening measures due to the transition to electronic clinical data systems.UnitedHealth’s preliminary disclosure applies to Star Year 2026 and impacts payment year 2027, a key driver of future Medicare Advantage reimbursements.&nbsp;On Stocktwits, retail sentiment for UnitedHealth&nbsp;flipped to ‘bullish’ late Tuesday, versus ‘bearish’ a day ago, amid&nbsp;a 181% spike in 24-hour&nbsp;message volume.<a href="https://stocktwits.com/symbol/UNH">UnitedHealth’s stock</a> has declined 30.4% so far in 2025,&nbsp;weighing heavily on the Dow Jones Industrial Average and making it among the worst S&amp;P 500 performers this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the UnitedHealth Group logo is displayed on the screen of a smartphone. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

UnitedHealth Fuels Bullish Mood With 4-Month High Close As Medicare Star Ratings, Reaffirmed 2025 Outlook Ease Investor Fears

Analysts also noted UNH broke from the usual “embargo period” by releasing preliminary ratings before CMS publishes official data.

UnitedHealth Reaffirms 2025 EPS Guidance: Time to Buy or Wait?

UNH reaffirms its 2025 EPS outlook, but mounting costs, legal probes and valuation pressures cloud the path ahead.

UnitedHealth Group Inc. (UNH) announced on Tuesday that it expects enrollment in its top-rated Medicare plans to be in line with expectations and historical trends.In a filing with the U.S. Securities and Exchange Commission on Tuesday, UnitedHealth stated that it estimates 78% of its memberships will be in four-star or higher-rated plans in its portfolio.<a href="https://stocktwits.com/symbol/UNH">UNH stock</a> soared more than 4% in Tuesday’s pre-market trade. Retail sentiment on Stocktwits around the company trended in the ‘bearish’ territory.While the data for 2026 star ratings provided by the Centers for Medicare &amp; Medicaid Services (CMS) is not yet available, UnitedHealth has made an estimate based on its preliminary review. The insurer also reaffirmed its adjusted earnings per share (EPS) expectations for 2025.Stocktwits data indicates that UnitedHealth is expected to report EPS of $2.81 on revenue of $113 billion in the third quarter (Q3). For the full fiscal year 2025, UNH’s EPS is expected to come in at $16.23, down from the 2024 EPS of $27.6. Revenue is expected to rise to $448 billion in 2025, from $401 billion in 2024.Senators Elizabeth Warren and Ron Wyden recently&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/elizabeth-warren-ron-wyden-blast-united-health-for-hardball-loan-tactics-tied-to-healthcare-unit-s-ransomware-breach/chtR62xRdZe">criticized</a> UnitedHealth over the company’s “hardball” tactics to recoup emergency loans issued to healthcare providers following a February 2024 ransomware attack that hit the health insurer’s Change Healthcare unit.UnitedHealth said it lent more than $9 billion under the Temporary Funding Assistance Program to providers struggling during the cyberattack. Warren called UNH’s repayment demands “deeply troubling.”<a href="https://stocktwits.com/symbol/UNH">UNH stock</a> is down 37% year-to-date and 46% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/dow-futures-edge-lower-ahead-revised-jobs-data/chwKc35RdsC">Dow Futures Edge Lower As Wall Street Cautiously Awaits Revised Jobs Data: AAPL, WOLF, ASML, CASY Among Stocks To Watch</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Why Is UNH Stock Rising Today?

In an SEC filing on Tuesday, UnitedHealth stated that it estimates 78% of its memberships will be in four-star or higher-rated plans in its portfolio.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

UNH
Unitedhealth Group Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest UNH News

UNH Unitedhealth Group Inc